Qianqian Qu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qianqian Qu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Chen Ping
Department of Neurology, Jiaozuo People’s Hospital of Henan Province, Henan, People’s Republic of China
1 shared publicationCui Wenhao
Department of Neurology, Jiaozuo People’s Hospital of Henan Province, Henan, People’s Republic of China
1 shared publication- Enzi Feng
The Third Affiliated Hospital of Kunming Medical University, Department of Head and Neck Surgery, Kunming, China
1 shared publication - Haidong Lv
Neurology Department, Jiaozuo People’s Hospital Affiliated to Henan Medical University, Jiaozuo City, China
1 shared publication - Jie Yang
The Third Affiliated Hospital of Kunming Medical University, Department of Head and Neck Surgery, Kunming, China
1 shared publication Jingting Fu
Neurology Department, Jiaozuo People’s Hospital Affiliated to Henan Medical University, Jiaozuo City, China
1 shared publication
Latest Publications
- Open Access
- 16 February 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Clinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod
To investigate the clinical effects, changes in serum IgG levels, and follow-up observations following treatment with Efgartigimod in patients with anti-ac
- 16 February 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessClinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod
To investigate the clinical effects, changes in serum IgG levels, and follow-up observations following treatment with Efgartigimod in patients with anti-ac
- Open Access
- 27 January 2025
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 91 (2) , 101551
LAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment
- 27 January 2025
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 91 (2) , 101551
Open AccessLAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment
- Open Access
- 31 July 2023
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 124 (1) , 91-99
Clinico-pathological and gene features of 15 nemaline myopathy patients from a single Chinese neuromuscular center
Background: Nemaline myopathy, the most common of the congenital myopathies, is caused by various genetic mutations. In this study, we attempted to investigate the clinical features, muscle pathology and genetic features of 15 patients with nemaline myopathy. Results: Among the 15 patients, there were 9 (60.00%) males and 6 (40.00%) females, and 9 (60.00%) of them came from three families respectively. The age of seeing a doctor ranged from 9 to 52 years old, the age of onset was from 5 to 23 years old, and the duration of disease ranged from 3 to 35 years. Ten out of the 15 patients had high arched palate and elongated face. Only one patient had mild respiratory muscle involvement and none had dysphagia. Muscle biopsies were performed in 9 out of the 15 patients. Pathologically, muscle fibers of different sizes, atrophic muscle fibers and compensatory hypertrophic fibers could be found, and occasionally degenerated and necrotic muscle fibers were observed. Different degrees of nemaline bodies aggregation could be seen in all 9 patients. The distribution of type I and type II muscle fibers were significantly abnormal in patients with nemaline myopathy caused by NEB gene, however, it was basically normal in patients with nemaline myopathy caused by TPM3 gene and ACTA1 gene. Electron microscopic analysis of 6 patients showed that nemaline bodies aggregated between myofibrils were found in 5(83.33%) cases, and most of them were located near the Z band, but no intranuclear rods were found. The gene analysis of 15 NM patients showed that three NM-related genes were harbored, including 11 (73.33%) patients with NEB, 3 (20.00%) patients with TPM3, and 1 (6.67%) patient with ACTA1, respectively. A total of 12 mutation sites were identified and included 10 (83.33%) mutations in exon and 2(16.67%) mutations in intron. Conclusions: The clinical phenotype of nemaline myopathy is highly heterogeneous. Muscle pathology shows that nemaline bodies aggregation is an important feature for the diagnosis of NM. NEB is the most frequent causative gene in this cohort. The splicing mutation, c.21522 + 3A > G may be the hotspot mutation of the NEB gene in Chinese NM patients.
- 31 July 2023
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 124 (1) , 91-99
Open AccessClinico-pathological and gene features of 15 nemaline myopathy patients from a single Chinese neuromuscular center
Background: Nemaline myopathy, the most common of the congenital myopathies, is caused by various genetic mutations. In this study, we attempted to investigate the clinical features, muscle pathology and genetic features of 15 patients with nemaline myopathy. Results: Among the 15 patients, there were 9 (60.00%) males and 6 (40.00%) females, and 9 (60.00%) of them came from three families respectively. The age of seeing a doctor ranged from 9 to 52 years old, the age of onset was from 5 to 23 years old, and the duration of disease ranged from 3 to 35 years. Ten out of the 15 patients had high arched palate and elongated face. Only one patient had mild respiratory muscle involvement and none had dysphagia. Muscle biopsies were performed in 9 out of the 15 patients. Pathologically, muscle fibers of different sizes, atrophic muscle fibers and compensatory hypertrophic fibers could be found, and occasionally degenerated and necrotic muscle fibers were observed. Different degrees of nemaline bodies aggregation could be seen in all 9 patients. The distribution of type I and type II muscle fibers were significantly abnormal in patients with nemaline myopathy caused by NEB gene, however, it was basically normal in patients with nemaline myopathy caused by TPM3 gene and ACTA1 gene. Electron microscopic analysis of 6 patients showed that nemaline bodies aggregated between myofibrils were found in 5(83.33%) cases, and most of them were located near the Z band, but no intranuclear rods were found. The gene analysis of 15 NM patients showed that three NM-related genes were harbored, including 11 (73.33%) patients with NEB, 3 (20.00%) patients with TPM3, and 1 (6.67%) patient with ACTA1, respectively. A total of 12 mutation sites were identified and included 10 (83.33%) mutations in exon and 2(16.67%) mutations in intron. Conclusions: The clinical phenotype of nemaline myopathy is highly heterogeneous. Muscle pathology shows that nemaline bodies aggregation is an important feature for the diagnosis of NM. NEB is the most frequent causative gene in this cohort. The splicing mutation, c.21522 + 3A > G may be the hotspot mutation of the NEB gene in Chinese NM patients.